Background Seasonal malaria chemoprevention (SMC) aims to prevent malaria in children
during the high malaria transmission season. The Achieving Catalytic Expansion of SMC in …

Background The intermittent administration of seasonal malaria chemoprevention (SMC) is
recommended to prevent malaria among children aged 3–59 months in areas of the Sahel …

Background In 2012, the WHO issued a policy recommendation for the use of seasonal
malaria chemoprevention (SMC) to children 3–59 months in areas of highly seasonal …

Background Seasonal malaria chemoprevention (SMC) has shown high protective efficacy
against clinical malaria and severe malaria in a series of clinical trials. We evaluated the …

Seasonal malaria chemoprevention (SMC) was recommended in 2012 for young children in
the Sahel during the peak malaria transmission season. Children are given a single dose of …

Seasonal malaria chemoprevention (SMC) for children< 5 is a strategy that is gaining
popularity in West African countries. Although its efficacy to reduce malaria incidence has …

Background Seasonal malaria chemoprevention (SMC) is a new strategy recommended by
WHO in areas of highly seasonal transmission in March 2012. Although randomized …

Background Malaria remains a leading cause of ill health, causing an estimated 216 million
cases of clinical malaria and 655 thousand deaths in 2010 a. More than 85% of malaria …

Background Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine
(SP) plus amodiaquine (AQ), given each month during the transmission season, is …

Background Seasonal malaria chemoprevention (SMC) is a new strategy to prevent malaria
in children under 5 years old. It has been recommended by the World Health Organization …